FindTrial
Sign In

Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-Analysis

Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-Analysis - Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049959
Enrollment
Unknown
Registered
2023-01-04
Start date
2022-08-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired pneumonia

Interventions

None listed

Sponsors

Japan Respiratory Society
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with community-acquired pneumonia aged 18 years or older.

Exclusion criteria

Exclusion criteria: Pediatric patients.

Design outcomes

Primary

MeasureTime frame
Prognosis, clinical efficacy, relapse of pneumonia, hospital days, adverse events, cost—

Countries

Japan

Contacts

Public ContactShotaro Ide

Nagasaki University Hospital Infectious Diseases Experts Training Center

str-ide@nagasaki-u.ac.jp095-819-7506

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026